{"version":"1.0","type":"link","title":"Second-line treatment strategy following CDK4/6 inhibitors for HR-positive and HER2-negative metastatic breast cancer patients: a multicentric, retrospective, observational study.","author_name":"Lavigne O 외","author_url":"https://prs-insight.online/author/Lavigne%20O","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/88465","thumbnail_width":1200,"thumbnail_height":630}